The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
930
September 2, 1994
View Complete Issue         Table of Contents 2019 
Issue 930
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Recombinant Human Growth Hormone
September 2, 1994 (Issue: 930)
Growth hormone has been in the news recently because of accusations of criminal misconduct in some marketing and prescribing practices (G Kolata, New York Times, August 15, 1994, page 1). The high cost of the drug and its widespread use for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 930
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.